Skip to Content. Use the menu to see other pages. This section explains the types of treatments that are the standard of care for early-stage and locally advanced breast cancer.
Breast cancer is the second most common cancer in women after skin cancer. Mammograms can detect breast cancer early, possibly before it has spread. Explore the links on this page to learn more about breast cancer prevention, screening, treatment, statistics, research, clinical trials, and more.
Breast cancer is cancer that develops from breast tissue. Risk factors for developing breast cancer include being female, obesitylack of physical exercise, drinking alcoholhormone replacement therapy during menopauseionizing radiationearly age at first menstruationhaving children late or not at all, older age, prior history of breast cancer, and family history. The balance of benefits versus harms of breast cancer screening is controversial.
After patients have completed treatment for early stage breast cancer, one of the common questions is "How should I best be monitored? At the current time, the standard approach for monitoring patients is a physical exam and a review of symptoms anywhere from every three to six months for the first two to three years, then every six months until year five, and annually thereafter. You should continue to have annual mammograms of the other breast. In some cases following a lumpectomy, we recommend a mammogram of the involved breast every six months for two to three years, and then yearly thereafter.
After a diagnosis of breast cancer, women tend to re-evaluate their nutrition and health practices. Many wonder what caused this cancer to occur and what lifestyle changes they should be making. Most women believe they must make significant dietary changes to ensure good outcomes following breast cancer treatment.
A less-invasive mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer has spread to nearby lymph nodes or who have risk factors for surgical complications, a Mayo Clinic study shows. In the procedure, known as a nipple-sparing mastectomy, surgeons remove breast tissue, leaving the skin, nipple and areola, and immediately rebuild the breasts. The findings are being presented at the American Society of Breast Surgeons annual meeting.
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates. Discover ESMO's new social media dashboard where you will find all your favourite posts and tweets in one place! ESMO40 Celebrate with us: watch our anniversary videos, take a virtual stroll through our timeline of 'ESMO firsts' or share your wishes for the future with us….
A federally funded study has found that many women with the most common type of early stage breast cancer likely do not need chemotherapy after surgery. It is likely to change the way many newly diagnosed breast cancer patients are treated. The higher the score, the greater the chance the cancer will come back. Previous studies have found that women with scores of 10 or lower did not need chemotherapy, while women with scores higher than 25 did benefit from chemotherapy.